MICRO-X LIMITED (MX1)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

MX1 - MICRO-X LIMITED
FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.32
Index:
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$0.12
27 Sep |
OPEN $0.12 |
HIGH $0.12 |
263,611 LOW $0.12 |
TARGET | |||||
|
OTHER COMPANIES IN THE SAME SECTOR | |||
4DX . AT1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . HLA . IDX . IME . IMR . IPD . LDX . MEB . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VHT . VTI . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | - 2.2 | - 0.8 | xxx |
DPS (cps) | xxx | N/A | 0.0 | xxx |
EPS Growth | xxx | N/A | N/A | xxx |
DPS Growth | xxx | N/A | N/A | xxx |
PE Ratio | xxx | N/A | N/A | xxx |
Dividend Yield | xxx | N/A | 0.0% | xxx |
Div Pay Ratio(%) | xxx | N/A | N/A | xxx |
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | -2.2 |
DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 15.0 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 3.3 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -11.0 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -71.67 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -59.17 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -47.65 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | -34.93 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | -59.17 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -70.10 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -11.8 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 1 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 4 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 5 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 5 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 3.60 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross

Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 0.8 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 5.19 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 22 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 9 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development

Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
MX1 STOCK CHART

FNArena News on MX1
1 |
Dr Boreham’s Crucible: Argenica Therapeutics10:00 AM - Small Caps |
2 |
FNArena Corporate Results Monitor – 31-08-2023Aug 31 2023 - Australia |
3 |
FNArena Corporate Results Monitor – 28-02-2023Feb 28 2023 - Australia |
4 |
FNArena Corporate Results Monitor – 31-08-2022Aug 31 2022 - Australia |
5 |
Rudi’s View: Adairs, Gentrack, ReadyTech, Macquarie, Qantas And NufarmOct 21 2021 - Rudi's View |
Latest Medical Equipment & Devices News
1 |
Dr Boreham’s Crucible: PainchekSep 11 2023 - Small Caps |
2 |
Margins Signal Integral Diagnostics RecoverySep 07 2023 - Australia |
3 |
ResMed: Finding A Base?Aug 15 2023 - Technicals |
4 |
August Turns ResMed Into Nigel NoMatesAug 09 2023 - Australia |
5 |
Dr Boreham’s Crucible: Lumos DiagnosticsJun 19 2023 - Small Caps |
6 |
Fisher & Paykel Healthcare: Lower Margin, Higher SpendingMay 30 2023 - Australia |
7 |
Dr Boreham’s Crucible: ImpedimedMay 08 2023 - Small Caps |
8 |
Treasure Chest: ResMed’s Benevolent MonopolyMay 01 2023 - Treasure Chest |
9 |
Dr Boreham’s Crucible: Volpara Health TechnologiesApr 26 2023 - Small Caps |
10 |
Dr Boreham’s Crucible: SDIMar 16 2023 - Small Caps |